BRIEF published on 11/15/2024 at 08:05, 6 days 2 hours ago Claranova at the Investir Day 2024 trade fair Shareholders Technological Innovation Strategy Claranova Invest Day
BRIEF published on 11/13/2024 at 18:05, 7 days 16 hours ago Claranova Reports Stable Revenue Amid Strategic Shifts Claranova PlanetArt Q1 Revenue Avanquest MyDevices Sale
PRESS RELEASE published on 11/13/2024 at 18:00, 7 days 16 hours ago Inside Information / Other news releases Claranova reports Q1 2024-2025 revenue of €89m with stable like-for-like performance, while focusing on core businesses and profitability targets Profitability Targets Claranova Core Businesses Q1 Revenue Like-for-like Performance
BRIEF published on 11/11/2024 at 18:05, 9 days 16 hours ago Claranova completes the acquisition of PlanetArt’s minority stakes Strategy Redemption Synergies Claranova PlanetArt
PRESS RELEASE published on 11/11/2024 at 18:00, 9 days 16 hours ago Inside Information / Other news releases Claranova announces buyout of all PlanetArt minority interests, implementing 'One Claranova' strategy. Transaction amount: €18.5m financed by borrowing, buyout price 40% lower than 2022 agreement Acquisition Strategy Claranova PlanetArt Buyout
BRIEF published on 11/05/2024 at 21:05, 15 days 13 hours ago Claranova: Publication of the Number of Voting Rights and Shares Share Capital Voting Rights Actions Regulation Claranova
BRIEF published on 10/31/2024 at 20:36, 20 days 14 hours ago Claranova publishes its 2023-2024 Universal Registration Document Financial Report Financial Agenda General Meeting Consolidated Accounts Claranova
PRESS RELEASE published on 10/31/2024 at 20:31, 20 days 14 hours ago Annual financial and audit reports / Terms of availability of the annual financial report Claranova announces availability of FY 2023-2024 Universal Registration Document including annual financial report. Consolidated financial statements approved and certified Consolidated Financial Statements Financial Report Universal Registration Document FY 2023-2024 Claranova
BRIEF published on 10/30/2024 at 20:05, 21 days 14 hours ago Claranova announces its General Meeting for December 2024 Financial Results Shareholders General Assembly Claranova Online Voting
BRIEF published on 10/04/2024 at 20:05, 1 month 16 days ago Claranova: Update of voting rights and capital as of September 30, 2024 Share Capital Voting Rights Financial Markets Authority Actions Claranova
Published on 11/21/2024 at 10:03, 41 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 44 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 44 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 9 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 19 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 14 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 39 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 41 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 44 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 44 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 46 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 24 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 59 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 59 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
